Latest Asia Pacific News

Ainsworth Game Technology shareholders will vote on a scheme of arrangement for acquisition by Novomatic AG, offering $1.00 cash per share including a potential fully franked dividend. The deal, valued at a 35% premium, awaits court approval in September.

Adslot Ltd has activated its StoreFront digital advertising platform across multiple international markets, driving $148.9 million in total transaction value for FY25 amid significant cost savings and a growing sales pipeline.

icetana Limited reports its strongest quarterly annual recurring revenue growth in over four years, boosted by a landmark $3.6 million strategic partnership with SoftBank Robotics Group and expanding global deployments.

Hiremii Limited reported a 4.4% revenue increase in Q4 FY25 alongside positive operating cash flow, while accelerating commercialisation of its proprietary AI recruitment platform and expanding through a key acquisition.

Telix Pharmaceuticals reported a robust 63% year-over-year revenue increase to $204 million in Q2 2025, launched its new prostate cancer imaging agent Gozellix in the U.S., and advanced key clinical trials despite an ongoing SEC inquiry.

Norwood Systems delivered its strongest quarter yet with record cash inflows, significant debt reduction, and expanding global partnerships, setting a robust foundation for FY2026.

Integrated Research reports a softer FY25 with declines in contract value and earnings, yet steady underlying revenue and promising AI-driven product launches signal a strategic pivot.

Ava Risk Group reports a positive EBITDA turnaround for FY2025 despite missing revenue guidance due to delayed key orders. The company highlights strong momentum in telecommunications and aviation sectors with promising technology deployments.

X2M Connect Limited has launched a $4.9 million capital raising through a Placement and Entitlement Offer to reduce debt and accelerate expansion in IoT, AI, and renewable energy markets.

AIMS Property Securities Fund has expanded its portfolio by acquiring a significant stake in AIMS APAC REIT at a notable discount, targeting an attractive dividend yield of over 8%.

Osteopore Limited has gained Swiss market approval for its 3D-printed bioresorbable implants under the EU Medical Device Regulation, completing its European product portfolio and strengthening its partnership with Zimmer Biomet.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.